OTCMKTS:MYDP Dougherty's Pharmacy (MYDP) Stock Price, News & Analysis → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free MYDP Stock Alerts $0.02 0.00 (0.00%) (As of 03/15/2021) Add Compare Share Share Today's Range$0.0150▼$0.015050-Day Range$0.0150▼$0.015052-Week Range$0.00▼$0.02Volume9,000 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Dougherty's Pharmacy alerts: Email Address Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. About Dougherty's Pharmacy Stock (OTCMKTS:MYDP)Dougherty's Pharmacy, Inc. focuses on acquiring, managing, and growing community based pharmacies in the Southwest Region of the United States. Its flagship store is Dougherty's Pharmacy, a turn-key multi-service pharmacy located in Dallas, Texas. The company was formerly known as Ascendant Solutions, Inc. and changed its name to Dougherty's Pharmacy, Inc. in May 2017. Dougherty's Pharmacy, Inc. was founded in 1929 and is based in Dallas, Texas.Read More MYDP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MYDP Stock News HeadlinesApril 17, 2024 | msn.comProsecutors describe John Dougherty's nephew as a workplace menace in extortion trial opening statementApril 13, 2024 | seekingalpha.comMark DoughertyApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. January 19, 2024 | health.usnews.comCaitlin J. DoughertyJanuary 13, 2024 | money.usnews.comPharmacy Technician SalaryDecember 16, 2023 | health.usnews.comAmy A. DoughertyNovember 3, 2023 | health.usnews.comJamie DoughertyOctober 10, 2023 | nypost.comWalgreens pharmacy employees plan walkout at US stores: reportApril 26, 2024 | Stansberry Research (Ad)Move Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. September 15, 2023 | health.usnews.comMary Jo DoughertySeptember 9, 2023 | health.usnews.comDiane L. DoughertyAugust 3, 2023 | forbes.comBest Student Loans For Pharmacy School Of July 2023July 19, 2023 | health.usnews.comDr. Thomas R. DoughertyJune 18, 2023 | mirror.co.ukFull list of 237 Lloyds Pharmacy branches closing TODAY inside Sainsbury's storesMay 20, 2023 | health.usnews.comJacob DoughertyApril 25, 2023 | health.usnews.comDr. Harry L. DoughertyApril 16, 2023 | thestreet.comNew York City Gets a Luxury PharmacyApril 3, 2023 | cnet.comHow Amazon Pharmacy's Automatic Coupon Feature WorksMarch 17, 2023 | detroitnews.comMadonna University hires new president from Philadelphia collegeMarch 12, 2023 | thestreet.comCVS Lawsuit Gives a Revealing Look at Amazon's Pharmacy AmbitionsMarch 1, 2023 | dailymail.co.ukLee Grace: 'Dougherty Gang' stripper smiling and loving the limelight in courtFebruary 28, 2023 | finance.yahoo.comTop Canadian Pharmacy in 2023 Helps Reduce Prescription Drug Costs in the U.S.February 23, 2023 | usnews.comDougherty Valley High SchoolFebruary 19, 2023 | marketwatch.comRetail Pharmacy Market 2023 New Threat With the Rise in Medical Care Industry 2029February 13, 2023 | msn.comCostco Pharmacy's Mail Order Program: What You Need To KnowJanuary 26, 2023 | businessinsider.comBillionaire Mark Cuban invested in digital-health's go-to pharmacy even though it struggled to keep up with orders from his drug-pricing companyJanuary 23, 2023 | mirror.co.ukFarmer, 80, secretly paid 900 neighbour's pharmacy bills for years to help outSee More Headlines Receive MYDP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dougherty's Pharmacy and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/14/2018Today4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug stores & proprietary stores Sub-IndustryN/A Current SymbolOTCMKTS:MYDP CUSIPN/A CIK1080029 Webwww.doughertys.com Phone972-250-0945Fax972-250-0934Employees75Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. James C. Leslie CPA (Age 66)CPA, Chairman, Interim Pres & CFO Comp: $100kMr. Stewart I. Edington (Age 52)Chief Exec. Officer Ms. Katherine BurrowManaging Director of Bus. Devel.Ms. Susan K. OlsonSec.Ms. Robin BruceControllerMr. Rick TrobermanExec. VP of Sales and MarketingMore ExecutivesKey CompetitorsDragon Jade InternationalOTCMKTS:DGJIHealth Sciences GroupOTCMKTS:HESG180 Life SciencesNASDAQ:ATNFW1933 IndustriesOTCMKTS:TGIFF3SBioOTCMKTS:TRSBFView All Competitors MYDP Stock Analysis - Frequently Asked Questions How have MYDP shares performed in 2024? Dougherty's Pharmacy's stock was trading at $0.0150 at the beginning of the year. Since then, MYDP shares have increased by 0.0% and is now trading at $0.0150. View the best growth stocks for 2024 here. How were Dougherty's Pharmacy's earnings last quarter? Dougherty's Pharmacy, Inc. (OTCMKTS:MYDP) announced its quarterly earnings data on Tuesday, August, 14th. The company reported ($0.02) EPS for the quarter. The business earned $9.17 million during the quarter. What other stocks do shareholders of Dougherty's Pharmacy own? Based on aggregate information from My MarketBeat watchlists, some companies that other Dougherty's Pharmacy investors own include Zynerba Pharmaceuticals (ZYNE), Armstrong World Industries (AWI), Bristol-Myers Squibb (BMY), National Vision (EYE), Floor & Decor (FND), Toronto-Dominion Bank (TD), Atlassian (TEAM), Altice USA (ATUS), How do I buy shares of Dougherty's Pharmacy? Shares of MYDP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MYDP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJim Cramer’s “The Biggest Drug Ever”Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dougherty's Pharmacy, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.